Efficacy testing of WR-2721 in Great Britain or everything is black and white at the gray lab
- 30 April 1983
- journal article
- editorial
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 9 (4) , 595-598
- https://doi.org/10.1016/0360-3016(83)90082-2
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Radioprotection of two mouse tumors by WR-2721 in single and fractionated treatmentsInternational Journal of Radiation Oncology*Biology*Physics, 1983
- Clinical trials of WR-2721 with radiation therapyInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Experimental radiotherapy with WR-2721 and misonidazoleInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Influence of WR 2721 on the efficacy of radiotherapy and chemotherapy of murine tumorsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Protective drugs in cancer therapy: Optimal clinical testing and future directionsInternational Journal of Radiation Oncology*Biology*Physics, 1982
- Radioprotection of mouse skin by WR-2721 in single and fractionated treatmentsThe British Journal of Radiology, 1982
- Differential Radioprotection of Euoxic and Hypoxic Mouse Mammary Tumors by a Thiophosphate CompoundRadiology, 1974
- Radioprotection of tumor and normal tissues by thiophosphate compoundsCancer, 1973
- Effect of Radioprotective Drugs on the Therapeutic Ratio for a Mouse Tumor SystemActa Radiologica: Therapy, Physics, Biology, 1973
- Radiobiological and Biochemical Studies of Thiophosphate Radioprotective Compounds Related to CysteamineRadiation Research, 1971